US4734401A
(en)
*
|
1986-03-17 |
1988-03-29 |
W. R. Grace & Co. |
Process for spray drying amino acid compositions
|
GB9001635D0
(en)
*
|
1990-01-24 |
1990-03-21 |
Ganderton David |
Aerosol carriers
|
US5464817A
(en)
*
|
1990-04-11 |
1995-11-07 |
Brigham And Women's Hospital |
Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5993805A
(en)
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5874063A
(en)
*
|
1991-04-11 |
1999-02-23 |
Astra Aktiebolag |
Pharmaceutical formulation
|
DE4140689B4
(de)
*
|
1991-12-10 |
2007-11-22 |
Boehringer Ingelheim Kg |
Inhalationspulver und Verfahren zu ihrer Herstellung
|
EP0630230B1
(en)
*
|
1992-03-10 |
1996-12-04 |
FISONS plc |
Pharmaceutical inhalation compositions
|
US6673335B1
(en)
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5668118A
(en)
*
|
1992-07-24 |
1997-09-16 |
Cavalier Pharmaceuticals |
Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
|
DE69334190T2
(de)
*
|
1992-07-24 |
2008-11-27 |
Kennedy, Thomas P. |
Nicht-antikoagulierende desulfatierte Heparine als Medikamente
|
US5296471A
(en)
*
|
1992-12-22 |
1994-03-22 |
Glycomed Incorporated |
Method for controlling o-desulfation of heparin and compositions produced thereby
|
US5696100A
(en)
*
|
1992-12-22 |
1997-12-09 |
Glycomed Incorporated |
Method for controlling O-desulfation of heparin and compositions produced thereby
|
GB9313650D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
GB9313642D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
DE4425255A1
(de)
*
|
1994-07-16 |
1996-01-18 |
Asta Medica Ag |
Formulierung zur inhalativen Applikation
|
GB9501841D0
(en)
*
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US6309671B1
(en)
*
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US6258341B1
(en)
*
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
US5980865A
(en)
*
|
1995-08-18 |
1999-11-09 |
Baker Norton Pharmaceuticals, Inc. |
Method for treating late phase allergic reactions and inflammatory diseases
|
US5690910A
(en)
*
|
1995-08-18 |
1997-11-25 |
Baker Norton Pharmaceuticals, Inc. |
Method for treating asthma
|
CA2234957C
(en)
*
|
1995-10-17 |
2006-12-19 |
Inge B. Henriksen |
Insoluble drug delivery
|
GB9606188D0
(en)
|
1996-03-23 |
1996-05-29 |
Danbiosyst Uk |
Pollysaccharide microspheres for the pulmonary delivery of drugs
|
IL126701A
(en)
*
|
1996-04-29 |
2001-08-08 |
Dura Pharma Inc |
Inhaler system for inhalation of a dry powder drug
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
JP4097044B2
(ja)
*
|
1996-07-29 |
2008-06-04 |
パリンジェニックス,インコーポレイテッド |
O―脱硫酸化ヘパリンで喘息を治療する方法
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5976574A
(en)
*
|
1996-12-31 |
1999-11-02 |
Inhale Therapeutic Systems |
Processes for spray drying hydrophobic drugs in organic solvent suspensions
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
US5804594A
(en)
*
|
1997-01-22 |
1998-09-08 |
Murad; Howard |
Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
|
GB9703673D0
(en)
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US20010046974A1
(en)
|
1997-06-06 |
2001-11-29 |
Hamilton Civic Hospitals Res Dev., Inc. |
Modified low molecular weight heparin that inhibits clot associated coagulation factors
|
AU7753898A
(en)
*
|
1997-06-06 |
1998-12-21 |
Hamilton Civic Hospitals Research Development, Inc. |
Modified low molecular weight heparin that inhibits clot associated coagulation factors
|
CA2209342A1
(en)
|
1997-06-30 |
1998-12-30 |
The University Of British Columbia |
Use of dextran and other oligomeric saccharides to improve airway clearance
|
IT1296998B1
(it)
|
1997-12-19 |
1999-08-03 |
Derivati Organici Lab |
Composizione costituita da frazioni di eparina avente caratteristiche riproducibili con peso molecolare medio di 5200 d
|
US20030118514A1
(en)
|
1998-03-26 |
2003-06-26 |
Glaxo Wellcome Inc. |
Compositions for inhalation
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
MA25590A1
(fr)
*
|
1998-09-14 |
2002-12-31 |
Inhale Therapeutic Syst |
Agent actif de delivraison de poudre seche
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
GB9827145D0
(en)
*
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US6926911B1
(en)
*
|
1998-12-22 |
2005-08-09 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
IT1309592B1
(it)
*
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
US6440463B1
(en)
|
1999-04-05 |
2002-08-27 |
Pharmaceutical Discovery Corporation |
Methods for fine powder formation
|
WO2000061178A1
(en)
*
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
US6223455B1
(en)
*
|
1999-05-03 |
2001-05-01 |
Acusphere, Inc. |
Spray drying apparatus and methods of use
|
US6560897B2
(en)
*
|
1999-05-03 |
2003-05-13 |
Acusphere, Inc. |
Spray drying apparatus and methods of use
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
GB2353222B
(en)
|
1999-06-23 |
2001-09-19 |
Cambridge Consultants |
Inhalers
|
BR0012202A
(pt)
|
1999-06-30 |
2002-04-02 |
Hamilton Civic Hospitals Res |
Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh
|
ITMI991582A1
(it)
*
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
ES2161615B1
(es)
*
|
1999-07-23 |
2003-03-16 |
Rovi Lab Farmaceut Sa |
Composiciones de heparinas de muy bajo peso molecular.
|
US20020081266A1
(en)
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
AU6679300A
(en)
*
|
1999-08-26 |
2001-03-26 |
Governors Of The University Of Alberta, The |
Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
|
WO2001032144A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Inhale Therapeutic Systems, Inc. |
Dry powder compositions having improved dispersivity
|
DE19953317C1
(de)
*
|
1999-11-05 |
2001-02-01 |
Pari Gmbh |
Inhalationsvernebler
|
EP1129705A1
(en)
*
|
2000-02-17 |
2001-09-05 |
Rijksuniversiteit te Groningen |
Powder formulation for inhalation
|
CA2340836A1
(en)
|
2000-03-18 |
2001-09-18 |
Degussa Ag |
Granular product
|
US6369115B1
(en)
*
|
2000-03-20 |
2002-04-09 |
Dura Pharmaceuticals, Inc. |
Stabilized powder formulations
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
US20050032745A1
(en)
|
2000-05-04 |
2005-02-10 |
Hamilton Civic Hospitals Res Dev., Inc. |
Modified low molecular weight heparin that inhibits clot associated coagulation factors
|
CN1197587C
(zh)
|
2000-06-09 |
2005-04-20 |
中国科学院上海细胞生物学研究所 |
N-位脱硫酸肝素在预防和治疗炎症中的应用
|
WO2002000197A1
(en)
*
|
2000-06-27 |
2002-01-03 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6969705B2
(en)
*
|
2000-07-21 |
2005-11-29 |
Aventis Pharma S.A. |
Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
UA75375C2
(en)
*
|
2000-10-12 |
2006-04-17 |
Boehringer Ingelheim Pharma |
Method for producing powdery preparations for inhaling
|
WO2002032406A2
(en)
|
2000-10-18 |
2002-04-25 |
Massachusetts Institute Of Technology |
Methods and products related to pulmonary delivery of polysaccharides
|
AU1850302A
(en)
|
2000-11-29 |
2002-06-11 |
Itoham Foods Inc |
Powdery preparations and proecss for producing the same
|
DK2283818T3
(en)
|
2000-11-30 |
2017-10-16 |
Vectura Ltd |
Process for preparing particles for use in a pharmaceutical composition
|
PT2283817T
(pt)
|
2000-11-30 |
2016-08-22 |
Vectura Ltd |
Método de fabrico de partículas para utilização numa composição farmacêutica
|
ES2689704T3
(es)
|
2000-11-30 |
2018-11-15 |
Vectura Limited |
Partículas para usar en una composición farmacéutica
|
GB0030074D0
(en)
|
2000-12-08 |
2001-01-24 |
Univ London Pharmacy |
Particulate inhalation carrier
|
CA2429773A1
(en)
*
|
2000-12-22 |
2002-07-04 |
Aspen Aerogels, Inc. |
Aerogel powder comprising therapeutic agents
|
GB0102902D0
(en)
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
GB0106403D0
(en)
|
2001-03-15 |
2001-05-02 |
Pharmaceutical Profiles |
Labelling of dry powder formulations for inhalation
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
DE10141376A1
(de)
*
|
2001-08-23 |
2003-03-13 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung von Inhalationspulvern
|
DE10141377A1
(de)
*
|
2001-08-23 |
2003-03-13 |
Boehringer Ingelheim Pharma |
Aufstreuverfahren zur Herstellung von Pulverformulierungen
|
EP1487417A4
(en)
|
2001-09-17 |
2010-03-17 |
Glaxo Group Ltd |
DRY POWDER DRUG FORMULATIONS
|
US20030091513A1
(en)
|
2001-10-03 |
2003-05-15 |
Mohsen Nahed M. |
Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension or dispersion media
|
ITMI20012174A1
(it)
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
US20050123509A1
(en)
|
2001-10-19 |
2005-06-09 |
Lehrman S. R. |
Modulating charge density to produce improvements in the characteristics of spray-dried proteins
|
AU2002335046A1
(en)
|
2001-10-19 |
2003-05-06 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
DE60227691D1
(de)
|
2001-11-01 |
2008-08-28 |
Nektar Therapeutics |
Sprühtrocknungsverfahren
|
KR20050044523A
(ko)
|
2001-11-19 |
2005-05-12 |
벡톤 디킨슨 앤드 컴퍼니 |
입자 형태의 약제학적 조성물
|
US20030166509A1
(en)
|
2001-11-20 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Compositions for sustained action product delivery and methods of use thereof
|
US20060188451A1
(en)
|
2001-12-21 |
2006-08-24 |
Aspen Aerogels, Inc. |
Aerogel based pharmaceutical formulations
|
US20030124087A1
(en)
|
2001-12-26 |
2003-07-03 |
Amitie Co. Ltd. |
Anti-adhesion barrier
|
DE60323973D1
(de)
*
|
2002-02-18 |
2008-11-20 |
Univ Southampton |
Verwendung von glykosaminglykanen wie z.b. heparin zur behandlung von atemerkrankungen wie copd
|
CA2516331C
(en)
*
|
2002-02-18 |
2013-04-23 |
University Of Southampton |
Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
|
ES2527096T3
(es)
*
|
2002-02-18 |
2015-01-20 |
Ockham Biotech Limited |
Combinación de ADNasa I y glucosaminoglucanos para su uso en limpieza de ADN extracelular
|
US20030232019A1
(en)
*
|
2002-02-22 |
2003-12-18 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
FI116657B
(fi)
|
2002-03-28 |
2006-01-31 |
Focus Inhalation Oy |
Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
|
AU2002308143A1
(en)
|
2002-04-12 |
2003-10-27 |
Campina Nederland Holding B.V. |
Excipient for use in dry powder inhalation preparations
|
EP1531795A4
(en)
|
2002-05-02 |
2011-02-23 |
Harvard College |
FORMULATIONS LIMITING THE EXTENSION OF PULMONARY INFECTIONS
|
US20050220720A1
(en)
|
2002-05-02 |
2005-10-06 |
David Edwards |
Formulations limiting spread of pulmonary infections
|
US20040028746A1
(en)
|
2002-08-06 |
2004-02-12 |
Sonke Svenson |
Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
|
GB0219512D0
(en)
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions with high drug ratios
|
GB0219511D0
(en)
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Method of preparing dry powder inhalation compositions
|
US20040043064A1
(en)
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
EP1556018A1
(en)
|
2002-09-30 |
2005-07-27 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
GB0226274D0
(en)
*
|
2002-11-11 |
2002-12-18 |
Medpharm Ltd |
Metered dose inhalation preparations
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
GB0300427D0
(en)
|
2003-01-09 |
2003-02-05 |
Univ Strathclyde |
Pharmaceutical composition
|
GB0304540D0
(en)
|
2003-02-27 |
2003-04-02 |
Elan Drug Delivery Ltd |
Particle formulation and its preparation
|
US6933372B2
(en)
*
|
2003-03-07 |
2005-08-23 |
Warner-Lambert Company |
Method to produce a solid form of heparin
|
EP1635786A2
(en)
|
2003-05-28 |
2006-03-22 |
Nektar Therapeutics |
Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agent microparticle with a partial or complete amino acid and/or phospholipid coat
|
CA2435632A1
(en)
|
2003-07-21 |
2005-01-21 |
Warren Hugh Finlay |
Formulation of powder containing nanoparticles for aerosol delivery to the lung
|
JP2007508240A
(ja)
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
DE10339197A1
(de)
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
PL1699434T3
(pl)
|
2003-09-02 |
2011-09-30 |
Norton Healthcare Ltd |
Sposób wytwarzania leku
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
WO2005025535A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Vectura Limited |
Methods for preparing pharmaceutical compositions
|
WO2005032483A2
(en)
*
|
2003-10-01 |
2005-04-14 |
Momenta Pharmaceuticals, Inc. |
Polysaccharides for pulmonary delivery of active agents
|
WO2005041933A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Teva Pharmaceutical Industries, Ltd. |
Nanoparticles for drug delivery
|
CN1261105C
(zh)
*
|
2003-12-05 |
2006-06-28 |
吉林省辽源亚东药业股份有限公司 |
一种复方吡拉西坦脑蛋白水解物制剂及制备方法
|
GB0329208D0
(en)
|
2003-12-17 |
2004-01-21 |
Ici Plc |
Particulate materials
|
WO2005061089A1
(en)
|
2003-12-23 |
2005-07-07 |
Niro A/S |
A method and apparatus for producing micro particles
|
US7928059B2
(en)
*
|
2004-02-24 |
2011-04-19 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for traumatic cartilage injury
|
SE528121C2
(sv)
|
2004-03-29 |
2006-09-05 |
Mederio Ag |
Preparering av torrpulver för på förhand uppmätt DPI
|
RU2347574C2
(ru)
*
|
2004-05-27 |
2009-02-27 |
Эвиджен, Инк. |
Способы лечения коагулопатий с использованием сульфатированных полисахаридов
|
US20050282775A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Paringenix, Inc. |
Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome
|
EP1768678A4
(en)
|
2004-06-30 |
2009-09-23 |
Paul L Deangelis |
METHODS FOR SELECTIVE TREATMENT OF DISEASES BY SPECIFIC GLYCOSAMINOGLYCAN POLYMERS
|
US20060014698A1
(en)
*
|
2004-07-14 |
2006-01-19 |
O'connor Michael F |
Nebulized pharmaceutical compositions for the treatment of bronchial disorders
|
US20060078623A1
(en)
|
2004-08-13 |
2006-04-13 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
US9061027B2
(en)
|
2004-08-27 |
2015-06-23 |
Board Of Regents, The University Of Texas System |
Enhanced delivery of drug compositions to treat life threatening infections
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
MX2007009635A
(es)
|
2005-02-10 |
2007-09-25 |
Orexo Ab |
Nuevas composiciones farmaceuticas utiles en la administracion transmucosa de farmacos.
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US7727555B2
(en)
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
JP2008533055A
(ja)
|
2005-03-18 |
2008-08-21 |
ナノマテリアルズ テクノロジー ピーティーイー リミテッド |
吸入剤
|
NZ562559A
(en)
|
2005-05-05 |
2011-03-31 |
Sanofi Aventis Us Llc |
Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles
|
CA2625532C
(en)
|
2005-10-12 |
2013-10-01 |
Seikagaku Corporation |
Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan
|
US20070098803A1
(en)
|
2005-10-27 |
2007-05-03 |
Primet Precision Materials, Inc. |
Small particle compositions and associated methods
|
US7597094B2
(en)
*
|
2005-11-29 |
2009-10-06 |
Leon Monroe Pittman |
Compound bow maintenance press and method for compressing a compound bow from the bow limb ends
|
GB0525254D0
(en)
|
2005-12-12 |
2006-01-18 |
Jagotec Ag |
Powder compositions for inhalation
|
US20080050444A1
(en)
|
2005-12-16 |
2008-02-28 |
Rajneesh Taneja |
Pharmaceutical compositions of ilaparazole
|
DE102005062270A1
(de)
|
2005-12-24 |
2007-06-28 |
Bayer Technology Services Gmbh |
Geschmacksmaskierung von Pulvern
|
US20070166386A1
(en)
|
2006-01-13 |
2007-07-19 |
Chinea Vanessa I |
Nanoparticle formation of pharmaceutical ingredients
|
KR20080105174A
(ko)
|
2006-04-03 |
2008-12-03 |
테바 파마슈티컬 인더스트리즈 리미티드 |
약물 미립자
|
EP2007358A4
(en)
|
2006-04-04 |
2012-01-25 |
Stc Unm |
INFLATING PARTICLES FOR THE ADMINISTRATION OF A MEDICINAL PRODUCT
|
WO2008054508A2
(en)
|
2006-04-13 |
2008-05-08 |
Alza Corporation |
Stable nanosized amorphous drug
|
US20080181958A1
(en)
|
2006-06-19 |
2008-07-31 |
Rothrock Ginger D |
Nanoparticle fabrication methods, systems, and materials
|
WO2008002485A2
(en)
|
2006-06-23 |
2008-01-03 |
Alza Corporation |
Increased amorphous stability of poorly water soluble drugs by nanosizing
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
EP1944018A1
(en)
|
2007-01-10 |
2008-07-16 |
CHIESI FARMACEUTICI S.p.A. |
Micronised particles of low-dosage strength active agents for powder formulations for inhalation
|
US20090203789A1
(en)
*
|
2008-01-31 |
2009-08-13 |
Multi Formulations Ltd. |
Fast Dissolution Amino Acid Composition
|